Enhancing apoE lipidation could also provide a new intervention strategy for late-onset Alzheimer’s disease, specifically for APOE4 carriers, because apoE4 is less lipidated than apoE2 or apoE36,69. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.